Issy les Moulineaux, France

Olivier Ardouin


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2000-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Olivier Ardouin: Innovator in Therapeutic Proteins

Introduction

Olivier Ardouin is a notable inventor based in Issy les Moulineaux, France. He has made significant contributions to the field of therapeutic proteins, particularly in the treatment of various injuries and disorders. With a total of 3 patents to his name, Ardouin's work focuses on the innovative use of the KAL protein.

Latest Patents

Ardouin's latest patents revolve around the use of the KAL protein in treating retinal, renal, neuronal, and neural injuries. The KAL protein has been identified as the active agent in a therapeutic composition aimed at addressing injuries to nerve tissue, including spinal cord tissue. This protein also supports the treatment of renal grafts. Furthermore, the therapeutic treatment of renal injury, kidney transplantation, and renal surgery can be effectively achieved through the administration of KAL protein, which may be delivered locally or intravenously. Retinal disorders can similarly benefit from this innovative treatment.

Career Highlights

Throughout his career, Olivier Ardouin has worked with prestigious institutions, including the Institut Pasteur. His research and innovations have significantly impacted the medical field, particularly in the area of nerve and kidney injury treatments.

Collaborations

Ardouin has collaborated with esteemed colleagues such as Christine Petit and Nadia Soussi-Yanticostas, contributing to the advancement of therapeutic applications in his field.

Conclusion

Olivier Ardouin's work exemplifies the intersection of innovation and medical science, particularly through his research on the KAL protein. His contributions continue to pave the way for advancements in the treatment of nerve and kidney injuries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…